{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:23:08Z","timestamp":1785410588181,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012558","name":"Sk\u00e5ne County Council's Research and Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13550-019-0536-3","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T12:02:54Z","timestamp":1564056174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-6211","authenticated-orcid":false,"given":"John","family":"Ly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Minarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edenbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Wollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Tr\u00e4g\u00e5rdh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"issue":"Suppl 1","key":"536_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-017-3727-z","volume":"44","author":"CS van der Vos","year":"2017","unstructured":"van der Vos CS, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):4\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"536_CR2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(10):1824\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"536_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, et al. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54(5):683\u201390.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"536_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","volume":"44","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):97\u2013110.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"536_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","volume":"127","author":"SF Barrington","year":"2016","unstructured":"Barrington SF, et al. PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood. 2016;127(12):1531\u20138.","journal-title":"Blood"},{"issue":"27","key":"536_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201368.","journal-title":"J Clin Oncol"},{"issue":"9","key":"536_CR7","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2967\/jnumed.117.189514","volume":"58","author":"David F.C. Hsu","year":"2017","unstructured":"Hsu DF, et al. Studies of a next generation silicon-photomultiplier-based time-of-flight PET\/CT system. J Nucl Med. 2017;58(9):1511\u201318.","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"536_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"536_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00259-018-3977-4","volume":"45","author":"A Kaalep","year":"2018","unstructured":"Kaalep A, et al. Feasibility of state of the art PET\/CT systems performance harmonisation. Eur J Nucl Med Mol Imaging. 2018;45(8):1344\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"536_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","volume":"44","author":"N Aide","year":"2017","unstructured":"Aide N, et al. EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):17\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"536_CR11","volume-title":"GE Healthcare. White paper","author":"S Ross","year":"2014","unstructured":"Ross S, Clear Q. GE Healthcare. White paper; 2014."},{"issue":"1","key":"536_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/cpf.12546","volume":"39","author":"M Sadik","year":"2019","unstructured":"Sadik M, et al. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET\/CT in Hodgkin and non-Hodgkin lymphomas. Clin Physiol Funct Imaging. 2019;39(1):78\u201384.","journal-title":"Clin Physiol Funct Imaging"},{"issue":"7","key":"536_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.117.202721","volume":"59","author":"B Enilorac","year":"2018","unstructured":"Enilorac B, et al. Does PET reconstruction method affect Deauville score in lymphoma patients? J Nucl Med. 2018;59(7):1049\u201355.","journal-title":"J Nucl Med"},{"issue":"1","key":"536_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13550-016-0177-8","volume":"6","author":"A Sher","year":"2016","unstructured":"Sher A, et al. For avid glucose tumors, the SUV peak is the most reliable parameter for [(18) F]FDG-PET\/CT quantification, regardless of acquisition time. EJNMMI Res. 2016;6(1):21.","journal-title":"EJNMMI Res"},{"issue":"1","key":"536_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40658-016-0169-9","volume":"4","author":"OL Munk","year":"2017","unstructured":"Munk OL, et al. Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative. EJNMMI Phys. 2017;4(1):5.","journal-title":"EJNMMI Phys"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-019-0536-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:07:02Z","timestamp":1595545622000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-019-0536-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s13550-019-0536-3","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Regional Ethical Review Board (#2016\/417) and was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}